New report published by Global Info Research which offers insights on the global Liposomes Drug Delivery market.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
Click to view the full report TOC, figure and tables:
Global Liposomes Drug Delivery Market: Forecast by Type / Application / Region
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The major players in global Liposome Drug Delivery market include: Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Teva Pharmaceutical, Ipsen (Onivyde), Fudan-Zhangjiang, CSPC, Novartis, Kingond Pharm, Shanghai New Asia, Spectrum Pharmaceuticals.
On the basis of product, the Liposome Drug Delivery market is primarily split into: Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Liposomal Bupivacaine, Other Liposomals.
On the basis on the end users/applications covers: Fungal Infection Therapy, Cancer & Tumor Therapy, Others.
In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 11.18%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.65 billion USD.
In consideration of the global economic and pharma industry, the growth rate of Liposomes Drug Delivery market will keep high in the next several years. The revenue market size expected to be 6.36 billion USD in 2025 at a CAGR of 11.58%.
North America dominated the market with market share of 44.97% due to the high medical level. Following North America, Europe is the second largest market with market share of 28.74%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 19.26%.
Liposomes have been used in a broad range of pharmaceutical applications. Liposomes are showing particular promise as intracellular delivery systems for anti-sense molecules, ribosomes, proteins/peptides, and DNA. Liposomes with enhanced drug delivery to disease locations, by ability of long circulation residence times, are now achieving clinical acceptance. Also, liposomes promote targeting of particular diseased cells within the disease site.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States Liposomes Drug Delivery Market 2018 Forecast to 2023
Europe Liposomes Drug Delivery Market 2018 Forecast to 2023
North America Liposomes Drug Delivery Market 2018 Forecast to 2023
Asia-Pacific Liposomes Drug Delivery Market 2018 Forecast to 2023
China Liposomes Drug Delivery Market 2018 Forecast to 2023
EMEA Liposomes Drug Delivery Market 2018 Forecast to 2023
Global Liposomes Drug Delivery Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong